Placeholder Banner

BIO Comments on NIH Proposed GDMO Research Guidelines

October 13, 2023

BIO submitted comments to the National Institutes of Health in response to the agency's request for comment on a proposal to review NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules to include specific considerations and requirements for research involving gene drive modified organisms (GDMOs) in contained research settings.

Download Full Comments Below
bio_comments_nih_proposed_gdmo_research_guidelines_final.pdf
Discover More
BIO provided general comments and recommended edits Re: FDA-2023-D-3031
BIO joins 30 other national trade associations in speaking out against unprecedented and burdensome FTC-DOJ regulation of mergers
BIO submits comments in response to the agency’s request for information (FDA-2023-N-3742)